The case for cytomegalovirus prophylaxis in solid organ transplantation.
about
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialDifferential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.Advances in the antiviral therapy of herpes virus infection in children.Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein.24 weeks of valganciclovir prophylaxis in children after renal transplantation: a 4-year experience.Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients.Cytomegalovirus infection of the major duodenal papilla in a renal allograft recipient with severe biliary obstruction and acalculous cholecystitis.Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients.Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation.Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
P2860
Q34786700-060A8515-E53C-4008-A63E-1721CCD84EB9Q35895301-2246BFA0-0F95-4421-B081-995C6E7B07CEQ36688958-CA6E90A2-C71E-488E-89F0-1871E77E5CBCQ36766049-FBB178FF-3083-4106-91F3-66F79190FB2EQ36929597-24A18546-D341-433E-A98D-849A758751DDQ37680941-4E063ACC-5A6E-49B4-B79D-D0C9D00D4ED2Q38875887-78DCA2C1-4717-44E0-9CA2-EA719455F399Q40115981-07A5B384-11ED-4425-8CB9-C175598F0ADBQ40399325-09EB7F59-E5A7-4348-8D6C-80F570763115Q42255903-773C4629-96FB-4A13-8D51-6B58EE09CE85Q42289035-F18DFFB6-FBED-4C2F-A309-679EAD1C3A78Q43002079-3C5D425F-1706-4F28-9FF1-0419CBE96078Q43517533-556ED6F4-BA8C-41DF-B510-EF6E20F54FCDQ44411974-E1C459C8-9CD6-4AAF-AC7F-FF1F4804418EQ48039802-A48EB475-25E0-436A-AD15-02D121A8BDF5Q58075077-1C408595-A20F-4231-AE91-B0BC26465172
P2860
The case for cytomegalovirus prophylaxis in solid organ transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@ast
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@en
type
label
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@ast
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@en
prefLabel
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@ast
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@en
P2860
P356
P1476
The case for cytomegalovirus prophylaxis in solid organ transplantation.
@en
P2093
David R Snydman
P2860
P304
P356
10.1002/RMV.514
P577
2006-09-01T00:00:00Z